These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Reducing adverse effects of proton pump inhibitors. Ament PW; Dicola DB; James ME Am Fam Physician; 2012 Jul; 86(1):66-70. PubMed ID: 22962914 [TBL] [Abstract][Full Text] [Related]
47. Proton Pump Inhibitors and the Kidney: Implications of Current Evidence for Clinical Practice and When and How to Deprescribe. Al-Aly Z; Maddukuri G; Xie Y Am J Kidney Dis; 2020 Apr; 75(4):497-507. PubMed ID: 31606235 [TBL] [Abstract][Full Text] [Related]
48. Proton Pump Inhibitors: What the Internist Needs to Know. Spechler SJ Med Clin North Am; 2019 Jan; 103(1):1-14. PubMed ID: 30466666 [TBL] [Abstract][Full Text] [Related]
49. Long-term safety concerns with proton pump inhibitors. Ali T; Roberts DN; Tierney WM Am J Med; 2009 Oct; 122(10):896-903. PubMed ID: 19786155 [TBL] [Abstract][Full Text] [Related]
50. Proton Pump Inhibitors: Risk for Myopathy? Colmenares EW; Pappas AL Ann Pharmacother; 2017 Jan; 51(1):66-71. PubMed ID: 27539734 [TBL] [Abstract][Full Text] [Related]
51. Efficacy and safety of proton pump inhibitors in the management of pediatric gastroesophageal reflux disease. Tjon JA; Pe M; Soscia J; Mahant S Pharmacotherapy; 2013 Sep; 33(9):956-71. PubMed ID: 23712734 [TBL] [Abstract][Full Text] [Related]
52. Association of Vitamin B12 deficiency with long-term PPIs use: A cohort study. Mumtaz H; Ghafoor B; Saghir H; Tariq M; Dahar K; Ali SH; Waheed ST; Syed AA Ann Med Surg (Lond); 2022 Oct; 82():104762. PubMed ID: 36268318 [TBL] [Abstract][Full Text] [Related]
53. Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infections. Laria A; Zoli A; Gremese E; Ferraccioli GF Reumatismo; 2011 Mar; 63(1):5-10. PubMed ID: 21509344 [TBL] [Abstract][Full Text] [Related]
54. Proton pump inhibitors (PPIs) may cause gastric cancer - clinical consequences. Waldum HL; Sørdal Ø; Fossmark R Scand J Gastroenterol; 2018 Jun; 53(6):639-642. PubMed ID: 29852782 [TBL] [Abstract][Full Text] [Related]
56. Long-term medical management of gastro-esophageal reflux disease: how long and when to consider surgery? Venkataraman J; Krishnan A Trop Gastroenterol; 2012; 33(1):21-32. PubMed ID: 22803292 [TBL] [Abstract][Full Text] [Related]
57. Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial. Björnsson E; Abrahamsson H; Simrén M; Mattsson N; Jensen C; Agerforz P; Kilander A Aliment Pharmacol Ther; 2006 Sep; 24(6):945-54. PubMed ID: 16948806 [TBL] [Abstract][Full Text] [Related]
58. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo Schey R; Alla SP; Midani D; Parkman HP Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467 [TBL] [Abstract][Full Text] [Related]
59. [Helicobacter pylori can in rare cases be the cause of iron and vitamin B 12 deficiency. No increased risk of iron and vitamin B 12 deficiency due to proton pump inhibitors]. Mattsson N; Kilander A; Björnsson E Lakartidningen; 2004 Jun; 101(23):2014-5. PubMed ID: 15232839 [TBL] [Abstract][Full Text] [Related]
60. Proton pump inhibitors and the kidney: critical review. Brewster UC; Perazella MA Clin Nephrol; 2007 Aug; 68(2):65-72. PubMed ID: 17722704 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]